Cronos (CRON) Capital Expenditures (2019 - 2026)
Cronos' (CRON) quarterly Capital Expenditures came in at $1.9 million in Q1 2026, down 87.71% year-on-year from $15.3 million in Q1 2025, and down 12.34% quarter-over-quarter from $2.1 million in Q4 2025.
Cronos (CRON) Capital Expenditures (2019 - 2026) Analysis & Trends
Cronos' Capital Expenditures history runs 8 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- On a quarterly basis, Capital Expenditures fell 87.71% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $12.3 million, a 52.46% decrease from a year earlier, with the FY2025 full-year figure at $25.7 million, up 107.21% from the prior year.
- Capital Expenditures slipped to $1.9 million in Q1 2026 per CRON's latest filing, from $2.1 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $15.3 million in Q1 2025 and bottomed at $67000.0 in Q3 2023.
- The 5-year median for Capital Expenditures is $1.5 million (2022), against an average of $2.7 million.
- Across the five-year window, Capital Expenditures sank 94.23% in 2022 and soared 9474.63% in 2024, its largest moves.
- Year by year, Capital Expenditures stood at $364000.0 in 2022, then jumped by 234.62% to $1.2 million in 2023, then jumped by 190.89% to $3.5 million in 2024, then sank by 39.63% to $2.1 million in 2025, then fell by 12.34% to $1.9 million in 2026.
- Per Business Quant, the three latest CRON Capital Expenditures figures stand at $1.9 million (Q1 2026), $2.1 million (Q4 2025), and $4.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.88 Mn |
| Mar 31, 2026 | 1.88 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Jun 30, 2025 | 3.84 Mn |
| Jun 30, 2025 | 3.84 Mn |
| Mar 31, 2025 | 15.26 Mn |
| Mar 31, 2025 | 15.26 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Sep 30, 2024 | 6.42 Mn |
| Sep 30, 2024 | 6.42 Mn |
| Jun 30, 2024 | 729,000.00 |
| Jun 30, 2024 | 729,000.00 |
| Mar 31, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.72 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Dec 31, 2023 | 1.22 Mn |